Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000212455 (LOC124900534) appears to encode or represent a predicted small nucleolar RNA (SNORA40), which generally functions in RNA modification in the nucleus. However, there is no evidence that this gene is protein-coding, nor is there meaningful data to support a defined biological function, implication in disease, or suitability as a therapeutic target. Its annotation as "RNU6-622P" and "SNORA40 (predicted)" reflects current bioinformatics categorization without experimental validation or clinical implication[4]. ENSG00000212455 is not reported to encode a protein or a receptor, and is not described as a drug target in Open Targets or related drug/gene databases[1][4]. The "SNORA" prefix refers to small nucleolar RNAs, a class of non-coding RNAs generally involved in chemical modification of other RNAs, such as rRNA, but there are no specific function or disease data for this predicted gene[4]. There is no evidence of disease association, drug interactions, or biomarker potential, and it is not listed as a therapeutic target in the available literature or databases. ENSG00000212455 is a predicted, likely non-coding small nucleolar RNA gene with no evidence of validated biological function, disease relevance, or druggability. Information is limited and likely incomplete or purely bioinformatic in nature, suggesting this is not a relevant therapeutic target and indicating the entry is primarily computational with insufficient experimental evidence[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA, SNORA40 (predicted) (SNORA40).